These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12704496)

  • 1. The hormone replacement therapy conundrum.
    Abushama MD; Ahmed BI
    Saudi Med J; 2003 Mar; 24(3):243-4. PubMed ID: 12704496
    [No Abstract]   [Full Text] [Related]  

  • 2. Health risks after cessation of postmenopausal hormone therapy.
    Pines A; Sturdee D; Birkhäuser M;
    Climacteric; 2008 Jun; 11(3):179-80. PubMed ID: 18568782
    [No Abstract]   [Full Text] [Related]  

  • 3. Do risks of hormone therapy persist after discontinuation?
    J Fam Pract; 2008 Jun; 57(6):366, 369. PubMed ID: 18677802
    [No Abstract]   [Full Text] [Related]  

  • 4. Individualising hormone replacement therapy.
    Attilakos G; Wardle PG
    Practitioner; 2002 May; 246(1634):295-8, 302, 305 passim. PubMed ID: 12043347
    [No Abstract]   [Full Text] [Related]  

  • 5. Hormone replacement therapy and breast cancer: what are the facts?
    Kricker A; Armstrong BK
    Med J Aust; 1996 Mar; 164(6):379; author reply 380. PubMed ID: 8606667
    [No Abstract]   [Full Text] [Related]  

  • 6. Hormone replacement therapy and breast cancer: what are the facts?
    Prince RL; Geelhoed EA
    Med J Aust; 1996 Mar; 164(6):379; author reply 380. PubMed ID: 8606668
    [No Abstract]   [Full Text] [Related]  

  • 7. Hormone replacement therapy and breast cancer: what are the facts?
    Zalcberg JR; Siderov J
    Med J Aust; 1996 Mar; 164(6):379-80. PubMed ID: 8606669
    [No Abstract]   [Full Text] [Related]  

  • 8. [Only two secure indications left. Changing one's view of hormone replacement therapy].
    Fath R
    Dtsch Med Wochenschr; 2003 Oct; 128(43):2236. PubMed ID: 14608994
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of SERM on breast cancer and cardiovascular disease: making a comparison between raloxifene use and hormone replacement therapy on the risks of the diseases].
    Higuchi T; Mizunuma H
    Clin Calcium; 2004 Oct; 14(10):81-4. PubMed ID: 15577136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. I stopped taking hormone replacement therapy a year and a half ago after reports that there might be health risks associated with it. Now that I've been off hormones, do my health risks improve?
    Mayo Clin Health Lett; 2004 Aug; 22(8):8. PubMed ID: 15534954
    [No Abstract]   [Full Text] [Related]  

  • 11. [The SBU revises its view on estrogen replacement therapy in climacteric. Evidently increased risk of thrombosis and breast cancer].
    Hovelius B
    Lakartidningen; 2002 Jul; 99(28-29):3014-5. PubMed ID: 12170508
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hormone replacement therapy in postmenopausal women: all the treatments are not the same].
    Ribot C; Trémollieres F
    Gynecol Obstet Fertil; 2007 May; 35(5):388-97. PubMed ID: 17392010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Menopause. Hormone replacement therapy. Technical Commission for Hormone Replacement Therapy of the Gynecology and Obstetrics College of the Order of Physicians].
    Acta Med Port; 1997 Oct; 10(10):713-4. PubMed ID: 9477597
    [No Abstract]   [Full Text] [Related]  

  • 14. Post-menopausal hormone replacement therapy (cont'd): risk-benefit balance in the hot seat.
    Prescrire Int; 2004 Jun; 13(71):106-9. PubMed ID: 15233153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current issues in hormone replacement therapy.
    Timins JK
    N J Med; 2004 Mar; 101(3):21-7. PubMed ID: 15042800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative review of the risks and benefits of hormone replacement therapy regimens.
    Warren MP
    Am J Obstet Gynecol; 2004 Apr; 190(4):1141-67. PubMed ID: 15118656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Conventional hormonal replacement therapy in treatment of osteoporosis].
    Meczekalski B; Czyzyk A
    Pol Merkur Lekarski; 2009 Jul; 27(157):72-6. PubMed ID: 19650436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Few Alternatives As HRT 'Fountain of Youth' Runs Dry.
    Schultz J
    J Natl Cancer Inst; 2004 Aug; 96(16):1202-3. PubMed ID: 15316054
    [No Abstract]   [Full Text] [Related]  

  • 19. The bioidentical hormone debate: are bioidentical hormones (estradiol, estriol, and progesterone) safer or more efficacious than commonly used synthetic versions in hormone replacement therapy?
    Holtorf K
    Postgrad Med; 2009 Jan; 121(1):73-85. PubMed ID: 19179815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse effects of hormone replacement therapy.
    Tripathi BK; Gupta B; Agarwal AK
    J Assoc Physicians India; 2001 Dec; 49():1176-80. PubMed ID: 11996438
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.